A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
